John Aballi

CIK: 0001843113

Transaction Breakdown

Open Market Buys (P)1 (11.1%)

High conviction signal

Open Market Sales (S)4 (44.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

XGN

EXAGEN INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

XGN
EXAGEN INC.
Oct 16, 2026
Sale(S)
Direct
34.3K shares at avg. $7.87$270K
XGN
EXAGEN INC.
Mar 12, 2026
Award(A)
Direct
150K shares-
XGN
EXAGEN INC.
Mar 3, 2026
Award(A)
Direct
2.5K shares at avg. $3.08$8K
XGN
EXAGEN INC.
Mar 3, 2026
Sale(S)
Direct
15.7K shares at avg. $3.62$57K
XGN
EXAGEN INC.
Feb 24, 2026
Sale(S)
Direct
11.4K shares at avg. $3.61$41K
XGN
EXAGEN INC.
Oct 16, 2025
Sale(S)
Direct
31.8K shares at avg. $11.82$376K
XGN
EXAGEN INC.
Feb 28, 2025
Award(A)
Direct
8.6K shares at avg. $2.46$21K
XGN
EXAGEN INC.
Feb 21, 2025
Award(A)
Direct
112.5K shares-
XGN
EXAGEN INC.
Nov 14, 2024
Purchase(P)
Direct
24.3K shares at avg. $2.81$68K

		Type	Shares	Price		Ownership
Oct 16, 2026	XGN EXAGEN INC.	Sale(S)	34,294	$7.87	$269,791	Direct
Mar 12, 2026	XGN EXAGEN INC.	Award(A)	150,000	-	$0	Direct
Mar 3, 2026	XGN EXAGEN INC.	Award(A)	2,535	$3.08	$7,800	Direct
Mar 3, 2026	XGN EXAGEN INC.	Sale(S)	15,698	$3.62	$56,827	Direct
Feb 24, 2026	XGN EXAGEN INC.	Sale(S)	11,430	$3.61	$41,262	Direct
Oct 16, 2025	XGN EXAGEN INC.	Sale(S)	31,787	$11.82	$375,598	Direct
Feb 28, 2025	XGN EXAGEN INC.	Award(A)	8,621	$2.46	$21,251	Direct
Feb 21, 2025	XGN EXAGEN INC.	Award(A)	112,500	-	-	Direct
Nov 14, 2024	XGN EXAGEN INC.	Purchase(P)	24,305	$2.81	$68,297	Direct

1-9 of 9 transactions

About ABALLI JOHN

ABALLI JOHN (SEC CIK 0001843113) files insider reports with the SEC as President and CEO of EXAGEN INC. (XGN).

Signal8 holds 9 ownership filings by ABALLI JOHN, all Form 4s, filed between Nov 18, 2024 and Oct 19, 2026. Those filings report 9 transactions, from Nov 14, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ABALLI JOHN's filings is in VISTA, CA.

Recent filings by ABALLI JOHN

Oct 16, 2026: Open-market sale of XGN shares (Form 4, code S).
Mar 12, 2026: Grant or award of XGN shares (Form 4, code A).
Mar 3, 2026: Grant or award of XGN shares (Form 4, code A).
Mar 3, 2026: Open-market sale of XGN shares (Form 4, code S).
Feb 24, 2026: Open-market sale of XGN shares (Form 4, code S).

Other insiders filing for EXAGEN INC. (XGN)

Nova Tina Susan, Director
Chernett Jorey, 10% Owner
Black Jeffrey G., Chief Financial Officer
Robertson Bruce C, Director
Kim Paul, Director
KAHN SCOTT D, Director

How to read Form 4 transaction codes